ESC 365 - New insights into optimal duration of DAPT for high-risk "TWILIGHT-like" patients with diabetes mellitus undergoing PCI: a focus on diabetes mellitus as a high-risk patient group

ESC Premium Access

New insights into optimal duration of DAPT for high-risk "TWILIGHT-like" patients with diabetes mellitus undergoing PCI: a focus on diabetes mellitus as a high-risk patient group

Session: Cardiovascular intervention: patient risk and technical features

Topic: Adjunctive Pharmacotherapy

Speaker: Doctor H. Wang (Beijing, CN)

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

Add to my library

About the speaker

Doctor Haoyu Wang

Fuwai Hospital, CAMS and PUMC, Beijing (China)

0 follower

2 more presentations in this session

Effect of risk enhancers versus technical aspects of high thrombotic risk criteria on adverse clinical events after PCI: insights from 2020 ESC NSTE-ACS Guidelines

Speaker: Doctor H. Wang (Beijing, CN)

Peripheral intravascular lithotripsy to facilitate transfemoral TAVR: a multicentric prospective registry

Speaker: Doctor G. Nardi (Florence, IT)

Access the full session

Cardiovascular intervention: patient risk and technical features

Speakers: Doctor H. Wang, Doctor H. Wang, Doctor G. Nardi

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources